Morgan Stanley Remains Bullish on UnitedHealth (UNH) Amid Sector Recovery

UnitedHealth Group Incorporated (NYSE:UNH) is included among the Billionaire Ken Fisher’s Top 11 Dividend Stock Picks.

On June 4, Morgan Stanley raised the firm’s price recommendation on UnitedHealth Group Incorporated (NYSE:UNH) to $453 from $395.  It reiterated an Overweight rating on the shares. Analyst Erin Wright noted that managed care stocks have been “grinding higher” as signs of softer utilization trends have started to emerge. The analyst also pointed to the potential impact of artificial intelligence across the managed care industry, saying AI could benefit both revenue growth and cost management. As those efficiencies scale, Morgan Stanley believes they could generate roughly 45% average EPS upside across the sector.

On June 8, Mizuho raised its price goal on UnitedHealth to $460 from $440. It maintained an Outperform rating on the stock. The firm said it believes the managed care sector is moving into a “more stable and predictable” policy environment. According to the analyst, the size and frequency of policy-related surprises are likely to ease from the elevated levels seen over the past three years. That shift could allow investors to focus more on company fundamentals, pricing recovery, and the sector’s underlying earnings potential. Mizuho also increased price targets across the managed care sector to reflect what it sees as a more stable regulatory and legislative backdrop.

UnitedHealth Group Incorporated (NYSE:UNH) is a healthcare and well-being company. Its operations are organized across four segments: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. The UnitedHealthcare business includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, and UnitedHealthcare Community & State.

READ NEXT: 10 Oversold Dividend Growth Stocks to Buy and 10 No-Brainer Dividend Stocks to Buy

Disclosure: None. Follow Insider Monkey on Google News.